This is the authors' abstract. We don't add key points for this paper.
Ruthenium has been supported on specifically chosen non‐reducible supports (Al 2 O 3 , SiO 2 , Al 2 O 3 ‐SiO 2 mixed oxides, Mg/ZnAl 2 O 4 spinel, and AlF 3 ), and these catalysts have been tested in the decomposition of nitrous oxide, N 2 O, to identify the catalytically active phase of ruthenium. Pure, bulk ruthenium dioxide, RuO 2 , and isolated Ru surface complexes have been synthesized and investigated for comparison. The catalysts were characterized by X‐ray diffraction, H 2 chemisorption, N 2 physisorption, temperature‐programmed reduction, and desorption (TPR/TPD) and in situ infrared spectroscopy (IR). All aimed experiments strongly indicate that the decomposition of N 2 O occurs on ruthenium dioxide, RuO 2 , instead of metal particles. H 2 pre‐reduction to Ru metal has inhibitory effects for all oxygen‐containing supports. The activity increases with the dispersion of ruthenium oxide. Bulk RuO 2 showed the best catalytic performance.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: